302 related articles for article (PubMed ID: 11882362)
21. Interleukin (IL)-15 in combination with IL-2, fms-like tyrosine kinase-3 ligand and anti-CD3 significantly enhances umbilical cord blood natural killer (NK) cell and NK-cell subset expansion and NK function.
Satwani P; van de Ven C; Ayello J; Cairo D; Simpson LL; Baxi L; Cairo MS
Cytotherapy; 2011 Jul; 13(6):730-8. PubMed ID: 21413839
[TBL] [Abstract][Full Text] [Related]
22. Distinctive response of naïve lymphocytes from cord blood to primary activation via TCR.
Cantó E; Rodriguez-Sanchez JL; Vidal S
J Leukoc Biol; 2003 Dec; 74(6):998-1007. PubMed ID: 12972509
[TBL] [Abstract][Full Text] [Related]
23. [Interleukin-12 restores and promotes the T-cell immune function inhibited by 5-fluorouracil].
Chi PD; Li L; Fan YY; Wu CY
Ai Zheng; 2007 Aug; 26(8):801-8. PubMed ID: 17697537
[TBL] [Abstract][Full Text] [Related]
24. Clonogenic capacity and ex vivo expansion potential of umbilical cord blood progenitor cells are not impaired by cryopreservation.
Almici C; Carlo-Stella C; Wagner JE; Mangoni L; Garau D; Re A; Giachetti R; Cesana C; Rizzoli V
Bone Marrow Transplant; 1997 Jun; 19(11):1079-84. PubMed ID: 9193749
[TBL] [Abstract][Full Text] [Related]
25. The regulation of phenotype and function of human liver CD3+/CD56+ lymphocytes, and cells that also co-express CD8 by IL-2, IL-12 and anti-CD3 monoclonal antibody.
Jin Y; Fuller L; Carreno M; Esquenazi V; Tzakis AG; Miller J
Hum Immunol; 1998 Jun; 59(6):352-62. PubMed ID: 9634197
[TBL] [Abstract][Full Text] [Related]
26. Ex vivo cytokine activation of peripheral blood stem cells: a potential role for adoptive cellular immunotherapy.
Meehan KR; Wu A; Hassan R; Miao Y; Chawla J; Slack R; Gehan E; Herscowitz HB
J Hematother Stem Cell Res; 2001 Apr; 10(2):283-90. PubMed ID: 11359675
[TBL] [Abstract][Full Text] [Related]
27. Umbilical cord blood-naive T cells but not adult blood-naive T cells require HLA class II on antigen-presenting cells for allo-immune activation.
Kloosterboer FM; van Luxemburg-Heijs SA; Willemze R; Falkenburg JH
Hum Immunol; 2004 Apr; 65(4):328-39. PubMed ID: 15120187
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-15 enhances the expansion and function of natural killer T cells from adult peripheral and umbilical cord blood.
Lin SJ; Huang YC; Cheng PJ; Lee PT; Hsiao HS; Kuo ML
Cytokine; 2015 Dec; 76(2):348-355. PubMed ID: 26481260
[TBL] [Abstract][Full Text] [Related]
29. Characterization of cord blood natural killer and lymphokine activated killer lymphocytes following ex vivo cellular engineering.
Ayello J; van de Ven C; Fortino W; Wade-Harris C; Satwani P; Baxi L; Simpson LL; Sanger W; Pickering D; Kurtzberg J; Cairo MS
Biol Blood Marrow Transplant; 2006 Jun; 12(6):608-22. PubMed ID: 16737934
[TBL] [Abstract][Full Text] [Related]
30. IL-12-secreting CD19-targeted cord blood-derived T cells for the immunotherapy of B-cell acute lymphoblastic leukemia.
Pegram HJ; Purdon TJ; van Leeuwen DG; Curran KJ; Giralt SA; Barker JN; Brentjens RJ
Leukemia; 2015 Feb; 29(2):415-22. PubMed ID: 25005243
[TBL] [Abstract][Full Text] [Related]
31. Increased frequency of CD3/8/56-positive umbilical cord blood T lymphocytes after allo-priming in vitro.
Hagihara M; Chargui J; Gansuvd B; Inoue H; Hotta T; Kato S
Ann Hematol; 2003 Mar; 82(3):166-70. PubMed ID: 12634949
[TBL] [Abstract][Full Text] [Related]
32. The mixed human umbilical cord blood-derived mesenchymal stem cells show higher antitumor effect against C6 cells than the single in vitro.
Jiao H; Yang B; Guan F; Li J; Shan H; Song L; Hu X; Liang S; Du Y; Jiang C
Neurol Res; 2011 May; 33(4):405-14. PubMed ID: 21535940
[TBL] [Abstract][Full Text] [Related]
33. [Mechanism of inhibitory effect of intravenous immunoglobulin on neonatal umbilical cord blood lymphocytes].
Hao YQ; Chen TX; Zhu YZ; Li QS
Zhonghua Er Ke Za Zhi; 2005 Jun; 43(6):438-43. PubMed ID: 16053731
[TBL] [Abstract][Full Text] [Related]
34. Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.
Lin SJ; Kuo ML
Cytotherapy; 2008; 10(4):397-405. PubMed ID: 18574772
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-15 enhances CD4(+) CD45RA(+) expression on umbilical cord blood mononuclear cells.
Lin SJ; Chao HC
Pediatr Allergy Immunol; 2001 Aug; 12(4):188-93. PubMed ID: 11555315
[TBL] [Abstract][Full Text] [Related]
36. Alloreactivity of ex vivo-expanded T cells is correlated with expansion and CD4/CD8 ratio.
Mercier-Letondal P; Montcuquet N; Sauce D; Certoux JM; Jeanningros S; Ferrand C; Bonyhadi M; Tiberghien P; Robinet E
Cytotherapy; 2008; 10(3):275-88. PubMed ID: 18418773
[TBL] [Abstract][Full Text] [Related]
37. Naive CD4+ cells from cord blood can generate competent Th effector cells.
Cantó E; Rodríguez-Sánchez JL; Vidal S
Transplantation; 2005 Sep; 80(6):850-8. PubMed ID: 16210975
[TBL] [Abstract][Full Text] [Related]
38. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
[TBL] [Abstract][Full Text] [Related]
39. Suppressive Characteristics of Umbilical Cord Blood-derived Regulatory T Cells After Ex Vivo Expansion on Autologous and Allogeneic T Effectors and Various Lymphoblastic Cells.
Vanichapol T; Pongsakul N; Srisala S; Apiwattanakul N; Chutipongtanate S; Hongeng S
J Immunother; 2019 May; 42(4):110-118. PubMed ID: 30921263
[TBL] [Abstract][Full Text] [Related]
40. Advances in umbilical cord blood cell therapy: the present and the future.
Berglund S; Magalhaes I; Gaballa A; Vanherberghen B; Uhlin M
Expert Opin Biol Ther; 2017 Jun; 17(6):691-699. PubMed ID: 28379044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
